MingMed Biotech

Company Deals

MingMed Biotech’s Hong Kong IPO Signals Push for First-in-Class Drugs

Fineline Cube Aug 18, 2022

Guangzhou-based MingMed Biotech has officially made an initial public offering (IPO) to the Hong Kong...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod